Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vivascope for real-time diagnosis of pancreatic solid lesion: A multicentre study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Same author

Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study.

The Journal of antimicrobial chemotherapy·2025
Same author

Timing of lumen-apposing metal stents removal in pancreatic fluid collections: Could we go beyond?

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2024
Same author

Effects of lenvatinib on glucose, cholesterol, triglycerides and estimated cardiovascular risk in patients with advanced thyroid cancer.

Endocrine·2024
Same author

New insights into aging in LiNiO<sub>2</sub> cathodes from high resolution paramagnetic NMR spectroscopy.

Chemical communications (Cambridge, England)·2024
Same author

Gender oncology: recommendations and consensus of the Italian Association of Medical Oncology (AIOM).

ESMO open·2024

Related Experiment Video

Updated: May 9, 2026

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

Total thyroidectomy for Graves' disease treatment.

A Catania1, E Guaitoli, G Carbotta

  • 1Departments of Surgical Sciences, and Experimental Medicine, Endocrinology Unit A, Sapienza University, Rome, Italy.

La Clinica Terapeutica
|July 23, 2013
PubMed
Summary

Total thyroidectomy is a safe Graves' disease treatment. This study found surgical management effective with manageable complications like transient hypocalcemia and disphony in patients with hyperthyroidism.

More Related Videos

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach
07:45

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach

Published on: November 28, 2025

Related Experiment Videos

Last Updated: May 9, 2026

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach
07:45

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach

Published on: November 28, 2025

Area of Science:

  • Endocrinology
  • Surgical Sciences

Background:

  • Graves' disease (GD) is the leading cause of hyperthyroidism globally, accounting for 60-80% of cases.
  • Diagnosis relies on clinical signs, TSH suppression, elevated free thyroxine (free T4), and triiodothyronine (free T3), alongside TRAb presence.
  • Treatment options include antithyroid drugs, radioactive iodine, and surgery.

Purpose of the Study:

  • To retrospectively review the safety and efficacy of surgical management for Graves' disease.
  • To assess postoperative complications in patients undergoing total thyroidectomy.

Main Methods:

  • Analysis of data from 50 patients with Graves' disease who underwent Total Thyroidectomy (TT) between 2005 and 2010.
  • Thirty-nine patients had TT for recurrent hyperthyroidism; eleven underwent TT for severe ophthalmopathy.
  • Mean follow-up period was 41 months.

Main Results:

  • Of 50 patients, 11 had pre-existing ophthalmopathy, and 4 developed it post-surgery.
  • Eleven patients experienced hypocalcemia, with 10 transient and 1 permanent.
  • Five patients had transient dysphonia.

Conclusions:

  • Total thyroidectomy is a safe and effective procedure for treating Graves' disease.
  • Complication rates for TT are comparable to subtotal thyroidectomy when performed by experienced surgeons.